Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.

Bharti, Alok C

Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) May 2004 - 5940-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0022-1767

10.4049/jimmunol.172.10.5940 doi


Animals
Bone Marrow Cells--cytology
Carrier Proteins--antagonists & inhibitors
Cell Differentiation--drug effects
Cell Line
Coated Pits, Cell-Membrane--drug effects
Curcumin--pharmacology
Enzyme Inhibitors--pharmacology
Growth Inhibitors--pharmacology
I-kappa B Kinase
I-kappa B Proteins--antagonists & inhibitors
Macrophages--cytology
Membrane Glycoproteins--antagonists & inhibitors
Mice
NF-KappaB Inhibitor alpha
NF-kappa B--antagonists & inhibitors
Osteoclasts--cytology
Phosphorylation--drug effects
Protein Serine-Threonine Kinases--antagonists & inhibitors
RANK Ligand
Receptor Activator of Nuclear Factor-kappa B
Signal Transduction--drug effects
Stem Cells--cytology